会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Nihonbashi Life Science HUB

2023年8月07日 (月) 午後 1:00 - 2023年8月07日 (月) 午後 5:00

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

DIA Risk Management Plan Forum 2023

概要

This Forum will be conducted in Japanese Language only.

Click Here to View the Program in Japanese

プログラム委員会

Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan
Hiroki Nagahama, MS Manager, Safety Evaluation & Risk Management Dept.,
GlaxoSmithKline K.K., Japan
Aiko Kumano Reviewer, Office of Safety II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hideo Nakada, RPh Deputy Associate Manager, Department of Hospital Pharmacy
Keio University, Japan
Kasumi Daidoji, PhD, RPh Associate Director, Clinical Planning & Development Dept., Medical Headquarters
Eisai Co., Ltd., Japan
Tomoko Yamada Associate director, Safety risk management, Pharmacovigilance
MSD K.K., Japan
Emiko Iida, MPharm
Daiichi Sankyo Co Ltd, Japan
Akiko Nishioka Clinical Research Associate, Clinical Operation
Novartis Pharma K.K., Japan
Toshifumi Sugizaki Reviewer, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Ayako Kurokawa
MSD K.K., Japan
Shogo Nakamori, MBA, MSc, RPh Senior Vice President & Managing Director, Japan, Korea, Singapore and Southeast
DIA, Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Download